Stay updated on Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the prior v3.4.2 entry.
    Difference
    0.0%
    Check dated 2026-03-07T09:56:52.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; this is a minor update that does not alter study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T05:13:00.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.0 to v3.4.1. No changes to study content or page functionality.
    Difference
    0.0%
    Check dated 2026-02-06T23:31:11.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Glossary visibility controls were added (Show glossary / Hide glossary). A page revision tag (Revision: v3.4.0) was introduced, a No FEAR Act Data entry added, and the label 'Last Update Submitted that Met QC Criteria' received capitalization adjustments.
    Difference
    0.2%
    Check dated 2026-01-23T17:15:06.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    No changes to the study content or outcomes; only revision metadata was updated (v3.3.4 added and v3.3.3 removed). To avoid alerting on small changes, set an alert condition.
    Difference
    0.0%
    Check dated 2026-01-16T12:08:19.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Locations section updated with numerous new sites across the US, Australia, and Europe, and several previously listed sites were removed. This broadens geographic access and may affect enrollment options for potential participants.
    Difference
    3%
    Check dated 2025-12-18T21:54:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.